About CellGenix
CellGenix is a company based in Freiburg Im Breisgau (Germany) founded in 1994 was acquired by Sartorius in July 2021. The company has 5 employees. CellGenix offers products and services including Cytokines and Growth Factors and Serum-free Media. CellGenix operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
- Headquarter Freiburg Im Breisgau, Germany
- Employees 5
- SectorsHealthcare
- Website cellgenix.com
- Social LinkedIn
- Acquired by Sartorius (Jul 2021)
- Legal Name Cellgenix Inc
Products & Services of CellGenix
CellGenix offers a comprehensive portfolio of products and services, including Cytokines and Growth Factors and Serum-free Media.
Raw materials for cell therapy and clinical manufacturing processes.
Media for ex vivo cell processing in gene therapy applications.
Investors in CellGenix
CellGenix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sartorius.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany |
Investor details for CellGenix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CellGenix
6 people are tracked at CellGenix (4 in leadership, 2 in team); the tracked headcount is 5.
| Name | Role | Group |
|---|---|---|
Daniel Spatz | Head Of Program Management & Operations Excellence Ats/ Managing Director Sartorius Cellgenix Gmbh | Leadership |
Bernd Leistler | Vice President Production | Leadership |
Daniel R. | Head Of IT / ERP Application Manager | Leadership |
Dr. Jürgen Branke | Head Of Quality Management | Leadership |
Florian Egner | Manager Of GMP Protein Production | Team |
Christophe Verolet | Member Of The Supervisory Board | Team |
Complete people profiles for CellGenix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CellGenix
2 dated milestones of CellGenix across 27 years, from founding to its latest funding, stage changes and deals.
- Founded CellGenix is founded.
- Exit Acquired by Sartorius.
Competitors of CellGenix
CellGenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| hitgen.com | 2012 | Lanzhou, China | $39.11M | – | DNA-encoded libraries are developed for drug discovery applications. |
Detailed competitors of CellGenix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CellGenix
Websites that share an audience with CellGenix (cellgenix.com).
Websites whose visitors overlap most with CellGenix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
gentaur.com | gentaur.com | 100% | – | #2,063,864 | – |
| lktlabs.com | 100% | – | #2,111,185 | View details | |
| cellsciences.com | 100% | 10.9K | #2,226,810 | View details | |
lclabs.com | lclabs.com | 100% | – | – | – |
| echelon-inc.com | 100% | 42.3K | #789,218 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for CellGenix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Cellgenix
Complete news archive for CellGenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CellGenix
10 companies that operate in the same segment as CellGenix (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CellGenix
CellGenix was founded in 1994.
CellGenix is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
CellGenix has 5 employees.
CellGenix is a supplier of high-quality reagents and tools for cell therapy and regenerative medicine. They were the first company to obtain a GMP manufacturing authorization for cell processing in Europe. Their product range includes: Serum-free media for the cultivation of dendritic cells, hematopoietic stem cells, T cells, NK cells, mesenchymal stem cells and human pluripotent stem cells (hESC, hPSC); Preclinical grade and GMP grade cytokines for optimal growth support andor differentiation of hematopoietic stem and progenitor cells, as well as dendritic cells, T cells, NK cells, MSC, ESC and iPS cells; FEP Bioprocessing containers with unique properties for cell culture and cryopreservation.
CellGenix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
CellGenix offers Cytokines and Growth Factors and Serum-free Media.
CellGenix has 1 investor. Key investors include Sartorius.
CellGenix operates through Cellgenix Inc.
Yes. CellGenix was acquired by Sartorius in July 2021.